|
|
|
|
Western blot - BCAR3 antibody (ab21705)

(enlarge)
|
|
|
|
|
Product Name
|
BCAR3 antibody
|
| |
See all BCAR3 antibodies (4)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Goat polyclonal to BCAR3
|
|
Immunogen
|
Synthetic peptide: RKLEPPPVKQAEL, corresponding to C terminal amino acids 813 - 825 of Human BCAR3. BLAST 'RKLEPPPVKQAEL' with or 
|
|
Reacts with
|
Hu
|
|
Predicted to react
(species key)
|
Cow (Due to sequence homology)
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions ELISA: Use at an assay dependent dilution. WB: Use at a concentration of 0.5 µg/ml.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Tags & Cell Markers >> Cell Type Markers >> Tumor Associated
|
|
Relevance
|
BCAR3 is a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. When overexpressed, it confers anti-estrogen resistance in breast cancer cell lines.
In breast cancer, the antiestrogen tamoxifen has been prescribed for both primary treatment and the treatment of advanced metastatic disease. Although the drug induces remission in most patients with estrogen receptor-positive disease, all patients eventually develop resistance. van Agthoven et al. (1998) applied an insertional mutagenesis strategy to a breast cancer cell line. Infected cells were subjected to tamoxifen selection, and the resistant clones were screened for a common integration site linked with antiestrogen resistance. By screening a human testis cDNA library with the integration site-specific probe, they obtained a cDNA encoding BCAR3 (breast cancer antiestrogen resistance 3). The deduced 825 amino acid BCAR3 protein contains a putative Src homology 2 (SH2) domain and sequences homologous to yeast CDC48. Northern blot analysis detected abundant expression of a 3.4kb BCAR3 transcript in heart, placenta, skeletal muscle, spleen, prostate, testis, ovary, small intestine, colon, fetal kidney, and several cancer cell lines, but not in nonmalignant breast tissue; a 6kb BCAR3 transcript was also detected in skeletal muscle and heart.
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Goat
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Storage buffer
|
Preservative: 0.02% Sodium Azide Constituents: 0.5% BSA, Tris buffered saline. pH 7.3 Material safety datasheet (MSDS) for this product: Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Concentration
|
0.500 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this BCAR3 antibody is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
|
See below for BCAR3 antibody images, references, products related to ab21705 and other tools.
|
| |
BCAR3 antibody images:
|
Western blot - BCAR3 antibody (ab21705)
BCAR3 antibody (ab21705) at 0.5 µg/ml + Cell lysates prepared from mouse kidney epithelial cells at 15 µg
|
| |
| |
|
Search PubMed (MEDLINE) for references to BCAR3
|
| |
BCAR3 antibody - more information
|
Customer reviews (feedback) regarding BCAR3 antibody |
Customer FAQs regarding BCAR3 antibody |
Protocols for BCAR3 antibody |
Price and availability of products related to BCAR3 antibody |
| |
BCAR3 antibody - related products:
|
|
|
| |
BCAR3 antibody - other tools:
|
Contact Abcam with a Technical Enquiry about BCAR3 antibody |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"